A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

NCT04607421 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

831

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Encorafenib
DRUG: Cetuximab
DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: 5-FU
DRUG: Capecitabine
DRUG: Bevacizumab

Sponsor

Pfizer

Collaborators

[object Object]
[object Object]
[object Object]